COVID-19 related thrombi in ascending and descending thoracic aorta with peripheral embolization: a case report.
Jan W BuikemaFolkert W. AsselbergsJanneke TekstraPublished in: European heart journal. Case reports (2021)
One-third of COVID-19 patients show major thrombotic events, mostly pulmonary emboli. The endothelial expression of angiotensin-converting enzyme-2 receptors makes it feasible that in patients with viraemia direct viral-toxicity to the endothelium of also the large arteries results in local thrombus formation. Up to date, prophylactic anticoagulants are recommended in all patients that are hospitalized with COVID-19 infections to prevent venous and arterial thrombotic complications.
Keyphrases
- sars cov
- coronavirus disease
- angiotensin converting enzyme
- end stage renal disease
- ejection fraction
- chronic kidney disease
- poor prognosis
- pulmonary artery
- nitric oxide
- spinal cord
- respiratory syndrome coronavirus
- prognostic factors
- peritoneal dialysis
- oxidative stress
- aortic valve
- endothelial cells
- risk factors
- patient reported outcomes
- coronary artery
- blood flow
- pulmonary arterial hypertension